References
Wiersema R, Jukarainen S, Eck RJ et al (2020) Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study. Crit Care 24(1):164. https://doi.org/10.1186/s13054-020-02886-7
Bianchi NA, Stavart LL, Altarelli M, Kelevina T, Faouzi M, Schneider AG (2021) Association of oliguria with acute kidney injury diagnosis, severity assessment, and mortality among patients with critical illness. JAMA Netw Open 4(11):e21333094. https://doi.org/10.1001/jamanetworkopen.2021.33094
Minor J, Smith A, Deutsch F, Kellum JA (2021) Automated versus manual urine output monitoring in the intensive care unit. Sci Rep 11(1):17429. https://doi.org/10.1038/s41598-021-97026-8
McMahon BA, Chawla LS (2021) The furosemide stress test: current use and future potential. Ren Fail 43(1):830–839. https://doi.org/10.1080/0886022X.2021.1906701
Albert C, Zapf A, Haase M et al (2020) Neutrophil gelatinase-associated lipocalin measured on clinical laboratory platforms for the prediction of acute kidney injury and the associated need for dialysis therapy: a systematic review and meta-analysis. Am J Kidney Dis 76(6):826–841
Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17(1):R25. https://doi.org/10.1186/cc12503
Kane-Gill S, Meersch M, Bell M (2020) Biomarker-guided management of acute kidney injury. Curr Opin Crit Care 26(6):556–562
Zarbock A, Küllmar M, Ostermann M et al (2021) Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg 133(2):292–302
Mehta S, Chauhan K, Patel A et al (2018) The prognostic importance of duration of AKI: a systematic review and meta-analysis. BMC Nephrol 19(1):91. https://doi.org/10.1186/s12882-018-0876-7
Hoste E, Bihorac A, Al-Khafaji A et al (2020) Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med. https://doi.org/10.1007/S00134-019-05919-0
Ostermann M, Zarbock A, Goldstein S et al (2020) Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open 3(10):e2019209. https://doi.org/10.1001/jamanetworkopen.2020.19209
Harrois A, Grillot N, Figueiredo S, Duranteau J (2018) Acute kidney injury is associated with a decrease in cortical renal perfusion during septic shock. Crit Care 22(1):161
Schneider AG, Molitoris BA (2020) Real-time glomerular filtration rate: improving sensitivity, accuracy and prognostic value in acute kidney injury. Curr Opin Crit Care 26(6):549–555. https://doi.org/10.1097/MCC.0000000000000770
De Vlieger G, Kashani K, Meyfroidt G (2020) Artificial intelligence to guide management of acute kidney injury in the ICU: a narrative review. Curr Opin Crit Care 26(6):563–573. https://doi.org/10.1097/MCC.0000000000000775
Chaudhary K, Vaid A, Duffy A et al (2020) Utilization of deep learning for subphenotype identification in sepsis-associated acute kidney injury. Clin J Am Soc Nephrol 15(11):1557–1565. https://doi.org/10.2215/CJN.09330819
Author information
Authors and Affiliations
Contributions
All authors contributed to the manuscript. The first draft was written by GDV, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
GDV has received speaker honoraria from Fresenius Medical Care and consultancy fees from Baxter. LF has received Research support and Lecture fees from Baxter, Fresenius, Ortho Clinical Diagnostics and Exthera Medical. AGS has received grants from the Leenaards foundation and B Braun Melsungen AG as well as speaker honoraria from Fresenius Medical Care, B Braun Melsungen AG and Jafron.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
De Vlieger, G., Forni, L. & Schneider, A. New diagnostics for AKI in critically ill patients: what to expect in the future. Intensive Care Med 48, 1632–1634 (2022). https://doi.org/10.1007/s00134-022-06843-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-022-06843-6